N0405078066.
Methods | Randomised controlled trial |
Participants | People with lung cancer |
Interventions | Venlafaxine versus placebo |
Outcomes | Effects on symptom profiles after 12 weeks (not clearly specified) |
Notes | According to the protocol the study has been completed, but no published or unpublished data have been retrieved. Not clear if the study is eligible. Authors did not reply to our request for clarification and for data. |